期刊文献+

利托君致不良反应文献分析 被引量:4

Literature Analysis of Adverse Drug Reactions Induced by Ritodrine
原文传递
导出
摘要 目的:了解利托君致不良反应(ADR)发生的特点、趋势及相关因素。方法:检索《中国期刊全文数据库》1999~2009年收载的有关利托君致ADR文献,筛选出符合卫生部ADR诊断标准的文献26篇,共337例ADR病例,并进行分类、统计、分析。结果:利托君ADR发生率为29.96%(337例/1125例);数种临床表现常合并出现,心血管系统的ADR发生率最高,有284例(占76.55%);因不能耐受而停药者占总用药人数的5.93%。结论:临床上使用利托君时应加强ADR监测,及时调整给药方法,以确保用药安全。 OBJECTIVE:To probe into the characteristics and the general pattern of adverse drug reactions(ADRs)induced by ritodrine and relevant factors. METHODS:26 literatures according with ADR diagnosis standard were retrieved from CNKI from 1999 to 2009. A total of 337 ADR cases induced by ritodrine were analyzed statistically. RESULTS:The incidence of ritodorine-inducing ADRs was 29.96%(337/1 125). Several clinical manifestations appeared simultaneously. ADR of cardiovascular system accounted for 76.55%(n=284). 5.93% of patients with ADR stop taking medicine because of poor drug tolerance. CONCLUSION: Great importance should be attached to ADR monitoring,adjustment of administration route to guarantee the safety of drug use.
出处 《中国药房》 CAS CSCD 北大核心 2010年第22期2095-2096,共2页 China Pharmacy
关键词 利托君 药品不良反应 合理用药 Ritodrine Adverse drug reaction Rational use of drugs
  • 相关文献

参考文献4

二级参考文献11

共引文献51

同被引文献26

  • 1胡福秀,张清连,马计唤.妊娠合并贫血的预防措施[J].中国优生与遗传杂志,2006,14(2):124-124. 被引量:11
  • 2董凤仙.骨科卧床患者便秘的护理干预[J].齐鲁护理杂志,2006,12(07B):1389-1389. 被引量:21
  • 3Descargues G, Mauger Tinlot F, Douvrin F, et al. Menses,fertilityand pregnancy after arterial embolization for the control of postpartumhaemorrhage[J]. Hum Reprod, 2004; 19(2):339-343.
  • 4Yju Y, Nakayama T. Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review[J]. Pharmacoepidemiol Drug Saf, 2006; 15:813.
  • 5Aysie karadag RN, MS, PHD. Effect of tow different short peripheral catheter materials on phlebitis development[J]. J Infusion Nurs, 2000; 23(3): 158-166.
  • 6Odi A, Collet F, Aiguier M, et al. Premature rupture of the membranes between 28 and 34 weeks of amenorrhea: Retrospective study apropos of 71 cases[J]. Gynecol Obstet Biol Reprod,2000; 29(6):599-606.
  • 7Chen B, Yancey MK, Antenatal corticosteroids in preterm premature rupture of membrane[J]. Clin Obstet Gynecol, 1998; 41 (4):832-841.
  • 8Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 1981, 30:239-245.
  • 9Crowley P. WITHDRAWN : Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev, 2007 (3): CD000065.
  • 10de Heus R, Mol BW, Erwich JJ, et al. Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study. BMJ, 2009, 338 :b744.

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部